Harman Max Bruins
Papers
5
Total Citations
2,910
H-Index
3
About
Dr. Harman Max Bruins is a leading urologic oncologist whose work has fundamentally shaped the global standard of care for bladder cancer. His primary research focuses on the management of muscle-invasive and metastatic bladder cancer, as well as upper tract urothelial carcinoma. Dr. Bruins is best known for his central role in authoring the European Association of Urology (EAU) Guidelines on Muscle-invasive and Metastatic Bladder Cancer. The 2020 edition of these guidelines, which has amassed over 2,100 citations, serves as a cornerstone reference for clinicians worldwide, synthesizing evidence to direct treatment strategies. His continued leadership in the 2023 update (with over 600 citations) ensures these recommendations remain current. Beyond guideline development, Dr. Bruins has made significant contributions through systematic reviews, such as his work comparing laparoscopic versus open nephroureterectomy for upper tract disease, which has informed surgical best practices. He has also provided practical clinical guidance on managing upper urinary tract complications following radical cystectomy. Through this blend of high-impact guideline authorship and focused clinical research, Dr. Bruins has directly influenced the treatment decisions of urologists and improved outcomes for patients facing aggressive urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5